About SAB Biotherapeutics, Inc. 
SAB Biotherapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 5 Schemes (4.43%)
Foreign Institutions
Held by 10 Foreign Institutions (1.92%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2025)
Net Profit:
-3 Million
Pharmaceuticals & Biotechnology
USD 201 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.67
-48.58%
1.22






